Evidence map›Paper›PMID 29648878›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2018

Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by Toll-like receptor 2.

Thomas K Hoang, Baokun He, Ting Wang, Dat Q Tran, J Marc Rhoads, Yuying Liu

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Role of ProbioticsInternational journal of molecular sciences · 2026
    Review
  8. Review
  9. Gut microbes · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. ProbioticNutrients · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Thomas K HoangDivision of Gastroenterology, Department of Pediatrics, The University of Texas Health Science Center at Houston McGovern Medical School , Houston, Texas.
Baokun HeDivision of Gastroenterology, Department of Pediatrics, The University of Texas Health Science Center at Houston McGovern Medical School , Houston, Texas.
Ting WangDivision of Gastroenterology, Department of Pediatrics, The University of Texas Health Science Center at Houston McGovern Medical School , Houston, Texas.
Dat Q TranDivision of Gastroenterology, Department of Pediatrics, The University of Texas Health Science Center at Houston McGovern Medical School , Houston, Texas.
J Marc RhoadsDivision of Gastroenterology, Department of Pediatrics, The University of Texas Health Science Center at Houston McGovern Medical School , Houston, Texas.
Yuying LiuDivision of Gastroenterology, Department of Pediatrics, The University of Texas Health Science Center at Houston McGovern Medical School , Houston, Texas.ORCID 0000-0003-3848-9254
The University of Texas Health Science Center at Houston · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Stability and potency of LAP+FOXP3+Tregs as novel cell therapy for GVHDR01HL113304 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI TRAN, DAT QUOC · 2012 to 2016
$1.9M
Mechanisms of L. reuteri in regulating intestinal inflammationR01AT007083 · NCCIH · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LIU, YUYING, RHOADS, JON MARC · 2014 to 2018
$1.7M
NCCIH NIH HHS R01 AT007083NHLBI NIH HHS R01 HL113304NIDDK NIH HHS P30 DK056338
6 · The paper itself

Abstract

Lactobacillus reuteri DSM 17938 (LR 17938) has been shown to reduce the incidence and severity of necrotizing enterocolitis (NEC). It is unclear if preventing NEC by LR 17938 is mediated by Toll-like receptor 2 (TLR2), which is known to mediate proinflammatory responses to bacterial cell wall components. NEC was induced in newborn TLR2

Indexed as

Enterocolitis, NecrotizingLimosilactobacillus reuteriAnimalsAnimals, NewbornAnti-Inflammatory AgentsDisease Models, AnimalInterleukin-1betaIntestinal MucosaIntestinesMiceProbioticsT-Lymphocytes, RegulatoryToll-Like Receptor 2Anti-Inflammatory AgentsInterleukin-1betaToll-Like Receptor 2Inflammationintestinal mucosalactobacillusnecrotizing enterocolitisToll-like receptor

Identifiers

PMID29648878
PMCPMC6139641
OpenAlexW2796929377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.